LeonaBio (LONA) Gains from Sales and Divestitures (2020 - 2026)
LeonaBio (LONA) reported Gains from Sales and Divestitures of $57601.0 for Q1 2026, up 3740.07% year-over-year from $1500.0 in Q1 2025, and down 2.66% quarter-over-quarter from $59177.0 in Q4 2025.
LeonaBio (LONA) Gains from Sales and Divestitures (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has 6 years of Gains from Sales and Divestitures data on file, last reported at $57601.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $57601.0, up 3740.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $57601.0 (up 3740.07% YoY), and the FY2025 annual result was $59177.0, down 90.47% from the prior year.
- Gains from Sales and Divestitures retreated to $57601.0 in Q1 2026 per LONA's latest filing, from $59177.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $620668.0 in Q4 2024 and troughed at $1500.0 in Q1 2025.
- A 4-year average of $170589.4 and a median of $119911.0 in 2022 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2022 and 2025: Gains from Sales and Divestitures soared 7508.57% in 2022, then plunged 99.03% in 2025.
- A 4-year view of Gains from Sales and Divestitures shows it stood at $119911.0 in 2022, then soared by 417.61% to $620668.0 in 2024, then sank by 90.47% to $59177.0 in 2025, then retreated by 2.66% to $57601.0 in 2026.
- Business Quant data shows LONA's Gains from Sales and Divestitures at $57601.0 in Q1 2026, $59177.0 in Q4 2025, and $29829.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,601.00 |
| Mar 31, 2026 | 57,601.00 |
| Dec 31, 2025 | 59,177.00 |
| Dec 31, 2025 | 59,177.00 |
| Sep 30, 2025 | 29,829.00 |
| Sep 30, 2025 | 29,829.00 |
| Jun 30, 2025 | 298,380.00 |
| Jun 30, 2025 | 298,380.00 |
| Mar 31, 2025 | 1,500.00 |
| Mar 31, 2025 | 1,500.00 |
| Dec 31, 2024 | 620,668.00 |
| Dec 31, 2024 | 620,668.00 |
| Sep 30, 2024 | 310,087.00 |
| Sep 30, 2024 | 310,087.00 |
| Jun 30, 2024 | 156,049.00 |
| Jun 30, 2024 | 156,049.00 |
| Mar 31, 2024 | 154,049.00 |
| Mar 31, 2024 | 154,049.00 |
| Dec 31, 2022 | 119,911.00 |
| Dec 31, 2022 | 119,911.00 |